ONK Therapeutics
ONK Therapeutics is a natural Killer Cell Therapies founded in 2015.
2
Funding Rounds
$29.5m
Money raised
Funding
Funding series
Funding Series Analysis
The company ONK Therapeutics has raised a total of $29.5m in funding over 2 rounds.
Key Insights:
- ONK Therapeutics Series A round, January 2022: $21.5m
- ONK Therapeutics , October 2020: $8m
ONK Therapeutics Series A round, January 2022
$21.5m
ONK Therapeutics , October 2020
$8m
Industries
ONK Therapeutics is active in the following industries: